Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AKUS

Akouos (AKUS) Stock Price, News & Analysis

Akouos logo

About Akouos Stock (NASDAQ:AKUS)

Advanced Chart

Key Stats

Today's Range
$13.29
$13.29
50-Day Range
$13.29
$13.29
52-Week Range
$2.32
$13.60
Volume
440 shs
Average Volume
344,411 shs
Market Capitalization
$490.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AKUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akouos and its competitors with MarketBeat's FREE daily newsletter.

AKUS Stock News Headlines

NOVARTIS AG's Net Worth
Joshua Makower's Net Worth
The Next Commodity Crisis Just Got a Name: Silver
Elon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to SpaceX to AI. And now, whispers are growing that his next move could be in silver. Why? Because silver is the lifeblood of EVs, solar panels, and AI tech.
William W. Backus Hospital
See More Headlines

AKUS Stock Analysis - Frequently Asked Questions

Akouos, Inc. (NASDAQ:AKUS) posted its quarterly earnings data on Friday, November, 12th. The company reported ($0.67) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.63) by $0.04.

Akouos (AKUS) raised $124 million in an initial public offering on Friday, June 26th 2020. The company issued 8,300,000 shares at a price of $14.00-$16.00 per share. BofA Securities, Cowen and Piper Sandler acted as the underwriters for the IPO and BTIG was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Akouos investors own include Advanced Micro Devices (AMD), Atreca (BCEL), Editas Medicine (EDIT), Homology Medicines (FIXX), Avidity Biosciences (RNA), Alector (ALEC) and Gossamer Bio (GOSS).

Company Calendar

Last Earnings
11/12/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:AKUS
CIK
1722271
Fax
N/A
Employees
103
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.62)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$86.67 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-45.09%
Return on Assets
-36.86%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
17.30
Quick Ratio
17.30

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.90 per share
Price / Book
2.71

Miscellaneous

Outstanding Shares
36,936,000
Free Float
35,163,000
Market Cap
$490.88 million
Optionable
Not Optionable
Beta
-0.55
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:AKUS) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners